Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries UPDATE 1-Catalent pushes into gene therapy with $1.2 bln buyout of Paragon Bioservices By: Reuters: Company News April 15, 2019 at 07:38 AM EDT Catalent Inc said on Monday it would buy privately held gene therapy-focused Paragon Bioservices Inc in an all-cash deal for $1.2 billion, helping the drug developer expand its capabilities to make specialized and costly treatments. Read More >> Related Stocks: Catalent Inc Novan Inc Rogers Corp Spark Therap Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
UPDATE 1-Catalent pushes into gene therapy with $1.2 bln buyout of Paragon Bioservices By: Reuters: Company News April 15, 2019 at 07:38 AM EDT Catalent Inc said on Monday it would buy privately held gene therapy-focused Paragon Bioservices Inc in an all-cash deal for $1.2 billion, helping the drug developer expand its capabilities to make specialized and costly treatments. Read More >> Related Stocks: Catalent Inc Novan Inc Rogers Corp Spark Therap
